NexThera, Oculis and Bayer Report Advances in Retinal Disease Therapies
Eye drops and fewer shots: NexThera, Oculis and Bayer move the needle in retinal disease care. NexThera, Bayer and Oculis…
Bayer’s Aflibercept 8 mg Eyes Six-Month Stretch Between Treatments
Bayer filed for EMA approval to extend aflibercept 8 mg treatment intervals to six months. Bayer (Leverkusen, Germany) submitted an…
latest posts
